Fosamax and Fosavance drugs – A national class wide settlement is approved

A national settlement agreement was approved by all the jurisdictions involved in the class actions regarding the Fosamax and Fosavance drugs. The claims process for members meeting eligibility criterias begins March 18th, 2017 and ends on July 17th, 2017. If you would like to be represented for your claim, please contact us at or (514) 937-2881 #238.

How can we help?